Product Code: RP-ID-10336571 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10336571
Market Overview:
Global Butterfly Needle Sets Market Size study, by Application (Blood transfusion, Venipuncture, IV rehydration and Delivery of medications), by End-User (Hospitals, Blood banks and Others) and Regional Forecasts 2020-2027
Global Butterfly Needle Sets Market is valued approximately at USD 166.6 million in 2019 and is anticipated to grow with a healthy growth rate of more than 8.2 % over the forecast period 2020-2027. A butterfly needle draws blood from an access vein or deliver intravenous (IV) therapy through a vein. It comprises of front to rear to a hypodermic needle with two bilateral flexible wings for flexible small-bore transparent tubing and lastly a connector. It is easy to use, much less painful for patients, reaches more body surface thus have more capacity to tolerates patient movements. The rise in prevalence of chronic diseases globally, precise and easy use of butterfly needles set and need for managing long term medication and drug infusion are the few factors responsible for growth of the market over the forecast period. For instance: according to World Federation of Neurology, nearly 12 out of 100 patients die due to neurological diseases. As per International Diabetes Federation, in 2019, the total number of diabetic patients suffering were 463 million in 2019 and is expected to rise to 700 million by 2045 worldwide and in 2019 there were 4.2 million people who died due to diabetes. Thus, rising number of chronic disease patients will increase the demand of butterfly needle sets which result in driving the growth of the market. However, lack of product innovation and regulatory standards is the major factor restraining the growth of global Butterfly Needle Sets market during the forecast period.
The regional analysis of global Butterfly Needle Sets market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific is the leading/significant region across the world in terms of market share owing to the the widespread adoption of butterfly needles and large pool of patients suffering from cancer and cardiovascular diseases, demand for blood transfusion and increase in the number of blood donors each year in this region.
Major market player included in this report are:
Braun Melsungen AG
Becton
Dickinson and Company
Nipro Corporation
Cardinal Health, Inc.
Medline Industries, Inc.
Terumo Corporation
Kawasumi Laboratories, Inc.
ISOMed
BioMatrix S.r.l.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Blood transfusion
Venipuncture
IV rehydration
Delivery of medications
By End-User:
Hospitals
Blood banks
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027
Target Audience of the Global Butterfly Needle Sets Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Becton
Dickinson and Company
Nipro Corporation
Cardinal Health, Inc.
Medline Industries, Inc.
Terumo Corporation
Kawasumi Laboratories, Inc.
ISOMed
BioMatrix S.r.l.
Related Reports
Proof of Quality & Reliability
